Latest Prescription Drugs news
Giving Nivolumab/Ipilimumab First Ups Overall Survival in Melanoma
posted December 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Most Immunosuppressive Meds Not Tied to Worse COVID-19 Outcomes
posted December 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Colchicine No Benefit Over Supportive Care for COVID-19
posted November 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
posted November 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
